By: Benzinga
Benzinga's Top Downgrades
Analysts at Sterne Agee downgraded Cree (NASDAQ: CREE ) from “buy” to “neutral.” The target price for Cree has been lowered from $66.00 to $59.00. Cree's shares closed at $61.11 yesterday. Analysts at Jefferies downgraded Cigna (NYSE: CI ) from “buy” to “hold.” The target price for Cigna
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here